Need for expanded HPV genotyping for cervical screening.

about

Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework

P2860

Q58749448-8BE23D2F-FD98-4313-9603-2B64D2929091

P2860

Need for expanded HPV genotyping for cervical screening.

Item

http://www.wikidata.org/entity/Q47599152

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Need for expanded HPV genotyping for cervical screening.

@en

Need for expanded HPV genotyping for cervical screening.

@nl

type

Item

label

Need for expanded HPV genotyping for cervical screening.

@en

Need for expanded HPV genotyping for cervical screening.

@nl

prefLabel

Need for expanded HPV genotyping for cervical screening.

@en

Need for expanded HPV genotyping for cervical screening.

@nl

P1476

Need for expanded HPV genotyping for cervical screening.

@en

P2093

Jack Cuzick

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.

Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results

Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.

P304

112-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1016/J.PVR.2016.05.004

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cosette M Wheeler

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29074170

http://www.w3.org/2001/XMLSchema#string

P932

5886893

http://www.w3.org/2001/XMLSchema#string

Need for expanded HPV genotyping for cervical screening.

about

P2860

P2860

Need for expanded HPV genotyping for cervical screening.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932